EMILY MURTHA: Open Payments
NPI 1770637001 · PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 34 payments from 12 companies in 2025. Trend: 2023 $981 · 2024 $816 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $149 |
| Melinta Therapeutics, LLC | 5 | $121 |
| Merck Sharp & Dohme LLC | 4 | $81 |
| ViiV Healthcare Company | 3 | $65 |
| Astellas Pharma US Inc | 2 | $52 |
| Lilly USA, LLC | 3 | $47 |
| PFIZER INC. | 2 | $47 |
| ABBVIE INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Rezzayo, Wegovy, Cresemba, MOUNJARO, PREVNAR 20, ZERBAXA, DOVATO, RUKOBIA.
Industry payments across ME — which companies pay providers there.
